Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Related Articles by Review for PubMed (Select 17356465)

1.

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P.

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82.

PMID:
17356465
2.

Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Wright EJ.

Curr Opin HIV AIDS. 2009 Sep;4(5):447-52. doi: 10.1097/COH.0b013e32832dd0c2. Review.

PMID:
20048710
3.

Neurocognitive dysfunction in the highly active antiretroviral therapy era.

Mothobi NZ, Brew BJ.

Curr Opin Infect Dis. 2012 Feb;25(1):4-9. doi: 10.1097/QCO.0b013e32834ef586. Review.

PMID:
22156897
4.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
5.

HIV-related neurocognitive impairment in the HAART era.

Robinson-Papp J, Elliott KJ, Simpson DM.

Curr HIV/AIDS Rep. 2009 Aug;6(3):146-52. Review.

PMID:
19589300
6.

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review.

Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ.

J Neurovirol. 2010 Mar;16(2):101-14. doi: 10.3109/13550281003682513. Review.

PMID:
20345318
7.

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.

Nicastri E, Leone S, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, Vella S, Narciso P, Corpolongo A, Andreoni M.

J Antimicrob Chemother. 2007 Oct;60(4):724-32. Epub 2007 Aug 21. Review.

8.

Assessing the efficacy of highly active antiretroviral therapy in the brain.

Kandanearatchi A, Williams B, Everall IP.

Brain Pathol. 2003 Jan;13(1):104-10. Review.

PMID:
12580550
9.

HIV, antiretroviral therapies, and the brain.

Liner KJ 2nd, Ro MJ, Robertson KR.

Curr HIV/AIDS Rep. 2010 May;7(2):85-91. doi: 10.1007/s11904-010-0042-8. Review.

PMID:
20425562
10.

Protease inhibitor monotherapy and the CNS: peace of mind?

Perez-Valero I, Bayon C, Cambron I, Gonzalez A, Arribas JR.

J Antimicrob Chemother. 2011 Sep;66(9):1954-62. doi: 10.1093/jac/dkr229. Epub 2011 Jun 13. Review.

11.

HIV-associated neurological disorders: a guide to pharmacotherapy.

Tan IL, McArthur JC.

CNS Drugs. 2012 Feb 1;26(2):123-34. doi: 10.2165/11597770-000000000-00000. Review.

PMID:
22201342
12.

[Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].

Clemente-Millana L, Portellano JA.

Rev Neurol. 2000 Dec 16-31;31(12):1192-201. Review. Spanish.

PMID:
11205557
13.

[Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].

Arendt G.

Fortschr Neurol Psychiatr. 2005 Oct;73(10):577-86. Review. German.

PMID:
16217698
14.

Neurologic and psychiatric complications of antiretroviral agents.

Raines C, Radcliffe O, Treisman GJ.

J Assoc Nurses AIDS Care. 2005 Sep-Oct;16(5):35-48. Review.

PMID:
16433108
15.
16.

HIV-1 associated dementia: symptoms and causes.

Ghafouri M, Amini S, Khalili K, Sawaya BE.

Retrovirology. 2006 May 19;3:28. Review.

17.

Promoting successful cognitive aging in adults with HIV: strategies for intervention.

Vance DE, Burrage JW.

J Gerontol Nurs. 2006 Nov;32(11):34-41. Review.

PMID:
17112136
18.

Neurocognitive impact of antiretroviral treatment: thinking long-term.

McPhail ME, Robertson KR.

Curr HIV/AIDS Rep. 2011 Dec;8(4):249-56. doi: 10.1007/s11904-011-0091-7. Review.

PMID:
21837444
19.

[Highly active antiretroviral therapy of neuro-AIDS. Side effects on the nervous system and interactions].

Husstedt IW, Reichelt D, Neuen-Jakob E, Hahn K, Kästner F, von Einsiedel R, Vielhaber B, Arendt G, Evers S.

Nervenarzt. 2009 Oct;80(10):1133-4, 1136-8, 1140-2. doi: 10.1007/s00115-009-2684-6. Review. German.

PMID:
19322555
20.

Oral lesions of HIV disease and HAART in industrialized countries.

Hodgson TA, Greenspan D, Greenspan JS.

Adv Dent Res. 2006 Apr 1;19(1):57-62. Review.

PMID:
16672551
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk